Cargando…

What happened to anti-malarial markets after the Affordable Medicines Facility-malaria pilot? Trends in ACT availability, price and market share from five African countries under continuation of the private sector co-payment mechanism

BACKGROUND: The private sector supplies anti-malarial treatment for large proportions of patients in sub-Saharan Africa. Following the large-scale piloting of the Affordable Medicines Facility-malaria (AMFm) from 2010 to 2011, a private sector co-payment mechanism (CPM) provided continuation of priv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tougher, Sarah, Hanson, Kara, Goodman, Catherine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5405529/ https://www.ncbi.nlm.nih.gov/pubmed/28441956 http://dx.doi.org/10.1186/s12936-017-1814-z

Ejemplares similares

Got ACTs? Availability, price, market share and provider knowledge of anti-malarial medicines in public and private sector outlets in six malaria-endemic countries
por: O'Connell, Kathryn A, et al.
Publicado: (2011)

Testing times: trends in availability, price, and market share of malaria diagnostics in the public and private healthcare sector across eight sub-Saharan African countries from 2009 to 2015
por: Hanson, Kara, et al.
Publicado: (2017)

WHO key access antibiotics price, availability and affordability in private sector pharmacies in Pakistan
por: Saleem, Zikria, et al.
Publicado: (2021)

The impact of the private sector co-payment mechanism (PSCM) on the private market for ACT in Nigeria: results of the 2018 cross-sectional outlet and household market surveys
por: Edwards, Hannah M., et al.
Publicado: (2022)

Determinants of price setting decisions on anti-malarial drugs at retail shops in Cambodia
por: Patouillard, Edith, et al.
Publicado: (2015)

Affordability of essential medicine prices in Malaysia’s private health sector
por: Ahmad, Nur Sufiza, et al.
Publicado: (2018)

The ACTwatch project: methods to describe anti-malarial markets in seven countries
por: Shewchuk, Tanya, et al.
Publicado: (2011)

Trends in access to anti‐malarial treatment in the formal private sector in Uganda: an assessment of availability and affordability of first‐line anti‐malarials and diagnostics between 2007 and 2018
por: Kibira, Denis, et al.
Publicado: (2021)

Price, availability and affordability of medicines
por: Mhlanga, Brenda S., et al.
Publicado: (2014)

Availability, prices and affordability of essential medicines for treatment of diabetes and hypertension in private pharmacies in Zambia
por: Kaiser, Andrea Hannah, et al.
Publicado: (2019)

India's family planning market and opportunities for the private sector: An analysis using the total market approach
por: Mozumdar, Arupendra, et al.
Publicado: (2019)

The private sector market for malaria rapid diagnostic tests in Nigeria: results of the 2018 market survey
por: Edwards, Hannah M., et al.
Publicado: (2022)

Pharmaceuticals imports in Tanzania: Overview of private sector market size, share, growth and projected trends to 2021
por: Wande, Dickson Pius, et al.
Publicado: (2019)

Market Prices
por: Beecher, Thos. K.
Publicado: (1885)

Prices, availability and affordability of medicines in Rwanda
por: Bizimana, Thomas, et al.
Publicado: (2020)

Methods for implementing a medicine outlet survey: lessons from the anti-malarial market
por: O’Connell, Kathryn A, et al.
Publicado: (2013)

Cost and affordability of non-communicable disease screening, diagnosis and treatment in Kenya: Patient payments in the private and public sectors
por: Subramanian, Sujha, et al.
Publicado: (2018)

Assessing the prices and affordability of oncology medicines for three common cancers within the private sector of South Africa
por: Mattila, Phyllis Ocran, et al.
Publicado: (2021)

Do anti-malarials in Africa meet quality standards? The market penetration of non quality-assured artemisinin combination therapy in eight African countries
por: Newton, Paul N., et al.
Publicado: (2017)

The Price and Market Share Evolution of the Original Biologics and Their Biosimilars in Finland
por: Luukkanen, Saana V., et al.
Publicado: (2022)

Two years post affordable medicines facility for malaria program: availability and prices of anti-malarial drugs in central Ghana
por: Freeman, Alexander, et al.
Publicado: (2017)

Medicine Prices, Availability, and Affordability in Private Health Facilities in Low-Income Settlements in Nairobi County, Kenya
por: Ongarora, Dennis, et al.
Publicado: (2019)

Socially-marketed rapid diagnostic tests and ACT in the private sector: ten years of experience in Cambodia
por: Yeung, Shunmay, et al.
Publicado: (2011)

Broken drug markets in infectious diseases: Opportunities outside the private sector?
por: Alpern, Jonathan D., et al.
Publicado: (2019)

Challenges constraining access to insulin in the private-sector market of Delhi, India
por: Sharma, Abhishek, et al.
Publicado: (2016)

Medicine prices, availability and affordability in Sri Lanka
por: Senarathna, S.M.D.K. Ganga, et al.
Publicado: (2011)

Availability, prices and affordability of essential medicines in Haiti
por: Chahal, Harinder Singh, et al.
Publicado: (2013)

The Collapse of the Price of Oil and the Importance of Fair Market Competition and Optimizing Public and Private Resources: Assessing Angola's Contraceptive Market Landscape
por: Harrison, Denise L
Publicado: (2017)

A cross-sectional study of the availability and price of anti-malarial medicines and malaria rapid diagnostic tests in private sector retail drug outlets in rural Western Kenya, 2013
por: Kioko, Urbanus, et al.
Publicado: (2016)

Biosimilar competition in European markets of TNF-alpha inhibitors: a comparative analysis of pricing, market share and utilization trends
por: Car, Elif, et al.
Publicado: (2023)

Pricing cycles and market movements
por: Faith, Curtis M, et al.
Publicado: (2010)

A total market approach for condoms in Myanmar: the need for the private, public and socially marketed sectors to work together for a sustainable condom market for HIV prevention
por: Htat, Han Win, et al.
Publicado: (2015)

Closing the access barrier for effective anti-malarials in the private sector in rural Uganda: consortium for ACT private sector subsidy (CAPSS) pilot study
por: Talisuna, Ambrose O, et al.
Publicado: (2012)

Availability of anticancer medicines in public and private sectors, and their affordability by low, middle and high-income class patients in Pakistan
por: Sarwar, Muhammad Rehan, et al.
Publicado: (2018)

SARS-CoV-2 testing in low- and middle-income countries: availability and affordability in the private health sector
por: Faust, Lena, et al.
Publicado: (2020)

Setting capitation payments in markets for health services
por: Ellis, Randall P., et al.
Publicado: (1987)

Price wars and price collusion in China's airline markets
por: Zhang, Yahua, et al.
Publicado: (2011)

Evaluating Drug Prices, Availability, Affordability, and Price Components: Implications for Access to Drugs in Malaysia
por: Babar, Zaheer Ud Din, et al.
Publicado: (2007)

The association between price, competition, and demand factors on private sector anti-malarial stocking and sales in western Kenya: considerations for the AMFm subsidy
por: O’Meara, Wendy Prudhomme, et al.
Publicado: (2013)

Is there transparency in the pricing of medicines in the South African private sector?
por: Bangalee, V, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_6gmh4jran34lunfavgr4mf7ea2